Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma (LESS)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2009 by Seoul National University Hospital.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Seoul National University Hospital
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT00945984
First received: July 22, 2009
Last updated: July 25, 2009
Last verified: July 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Surgical resection is the only potential curative treatment available for renal cell carcinoma. The purpose of this study is to clarify the surgical and oncologic outcomes of laparoendoscopic single-site radical nephrectomy for localized Renal Cell Carcinoma.
| Condition | Intervention |
|---|---|
|
Localized Renal Cell Carcinoma |
Procedure: Radical nephrectomy |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Retrospective |
| Official Title: | Comparison of Laparoendoscopic Single-site Radical Nephrectomy With Conventional Laparoscopic Radical Nephrectomy for Localized Renal Cell Carcinoma |
Further study details as provided by Seoul National University Hospital:
Primary Outcome Measures:
- Surgical outcomes such as operative time, estimated blood loss [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
| Enrollment: | 36 |
| Study Start Date: | March 2009 |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
LESS
Patients who underwent LESS radical nephrectomy
|
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma
|
|
Conventional laparoscopy
Patients who underwent conventional laparoscopic radical nephrectomy
|
Procedure: Radical nephrectomy
Surgical options to treat localized renal cell carcinoma
|
Eligibility| Ages Eligible for Study: | 20 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
Tertiary care center
Criteria
Inclusion Criteria:
- Patients with localized renal cell carcinoma
Exclusion Criteria:
- Patients with lymph node or distant metastasis
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00945984
Locations
| Korea, Republic of | |
| Seoul National University Hospital | |
| Seoul, Korea, Republic of, 110-744 | |
Sponsors and Collaborators
Seoul National University Hospital
Investigators
| Study Chair: | Hyeon Hoe Kim, PhD | Seoul National University Hospital |
More Information
No publications provided
| Responsible Party: | Hyeon Hoe Kim, Seoul National University Hospital |
| ClinicalTrials.gov Identifier: | NCT00945984 History of Changes |
| Other Study ID Numbers: | LESSRNx |
| Study First Received: | July 22, 2009 |
| Last Updated: | July 25, 2009 |
| Health Authority: | Korea: Ministry for Health, Welfare and Family Affairs |
Keywords provided by Seoul National University Hospital:
|
Localized renal cell carcinoma |
Additional relevant MeSH terms:
|
Carcinoma Carcinoma, Renal Cell Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Adenocarcinoma |
Kidney Neoplasms Urologic Neoplasms Urogenital Neoplasms Neoplasms by Site Kidney Diseases Urologic Diseases |
ClinicalTrials.gov processed this record on May 16, 2013